Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.

Details

Serval ID
serval:BIB_FE00FBD3FF24
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.
Journal
International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (cinp)
Author(s)
Nikisch G., Agren H., Eap C.B., Czernik A., Baumann P., Mathé A.A.
ISSN
1461-1457 (Print)
ISSN-L
1461-1457
Publication state
Published
Issued date
2005
Peer-reviewed
Oui
Volume
8
Number
3
Pages
403-410
Language
english
Notes
Publication types: Clinical Trial ; Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Abstract
Neuropeptides appear to play a role in the pathophysiology of depression and electroconvulsive treatment and lithium affect these compounds in human cerebrospinal fluid (CSF) and rodent brain. Consequently, we investigated whether long-term treatment with the selective serotonin reuptake inhibitor (SSRI) citalopram (Cit) would also affect neuropeptides in CSF of depressed patients. Changes in CSF monoamine metabolites were also explored. CSF concentrations of corticotropin-releasing hormone (CRH)-like immunoreactivity (-LI), neuropeptide Y (NPY)-LI, and Cit were determined in 21 patients with major depression. Lumbar puncture was performed in the morning at baseline and was repeated after at least 4 wk of Cit treatment (40 mg/d). The severity of depression was assessed by the Hamilton Rating Scale for Depression (HAMD). Cit treatment was associated with a significant increase in NPY-LI and decrease in CRH-LI. An evaluation of the relationship between changes in concentrations of NPY-LI, CRH-LI, and the clinical response showed significant correlations between these parameters. Significant NPY and CRH changes in CSF following treatment as well as correlations to changes in HAMD support the hypothesis that these two peptides play a role in affective disorders and are markers of therapeutic response.
Keywords
Adult, Analysis of Variance, Antidepressive Agents, Second-Generation/therapeutic use, Citalopram/therapeutic use, Corticotropin-Releasing Hormone/blood, Corticotropin-Releasing Hormone/cerebrospinal fluid, Depression/blood, Depression/cerebrospinal fluid, Female, Humans, Immunoassay/methods, Male, Middle Aged, Neuropeptide Y/blood, Neuropeptide Y/cerebrospinal fluid, Time Factors
Pubmed
Web of science
Open Access
Yes
Create date
01/03/2013 11:17
Last modification date
20/08/2019 16:28
Usage data